NCT01652703: A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects
- State
- Completed
- Phase
- Phase 2
- People
- 310 taking part
- Started
- 10 Jul 2012
- Primary completion
- 14 May 2013
- Arms
- Evolocumab 70 mg Q2W, Evolocumab 140 mg Q2W, Evolocumab 280 mg Q4W, Evolocumab 420 mg Q4W
- Results
- Posted on the registry
- 10 Jul 2012: Trial started
- 30 Jul 2012: Trial registered
- 5 Oct 2015: Trial results posted
- 28 Nov 2018: Trial completed